Is Edgewise Therapeutics, Inc. (EWTX) a Buy, Sell, or Hold?
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
$40.83 USD
$1.1 (2.77%)
- Volume
- 701.21K
- Average Volume
- 1.48M
- Market Capitalization
- $4.39B
- P/E Ratio
- -24.60
- Dividend Yield
- 0.00%
- Price Target
- $51.00
- Year High
- $48.40
- Year Low
- $12.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $22.61
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
26
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
24
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.04M
EWTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
EWTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Russell Alan J | director, officer: Chief Scientific Officer | 2026-07-01 | M-Exempt | 0.18 | 2026-07-02 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2026-07-01 | M-Exempt | 0.18 | 2026-07-02 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2026-07-01 | M-Exempt | 0.45 | 2026-07-02 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2026-07-01 | S-Sale | 39.406 | 2026-07-02 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2026-07-01 | S-Sale | 39.4089 | 2026-07-02 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2026-07-01 | M-Exempt | 0.45 | 2026-07-02 |
| Fox Jonathan C | director | 2026-07-01 | A-Award | 0 | 2026-07-01 |
| Brege Laura | director | 2026-06-05 | A-Award | 35.59 | 2026-06-17 |
| Thompson Peter A. | director, 10 percent owner: | 2026-06-05 | A-Award | 35.59 | 2026-06-17 |
| Morris Arlene | director | 2026-06-05 | A-Award | 35.59 | 2026-06-17 |
| Edris Badreddin | director | 2026-06-05 | A-Award | 35.59 | 2026-06-16 |
| Edris Badreddin | director | 2026-06-05 | A-Award | 0 | 2026-06-16 |
| Martin Christopher Nathan | director | 2026-06-05 | A-Award | 35.59 | 2026-06-16 |
| Fox Jonathan C | director | 2026-06-05 | A-Award | 35.59 | 2026-06-16 |
| Donovan Joanne M. | officer: CMO | 2026-05-05 | M-Exempt | 7.08 | 2026-05-05 |
| Donovan Joanne M. | officer: CMO | 2026-05-05 | M-Exempt | 7.08 | 2026-05-05 |
| Donovan Joanne M. | officer: CMO | 2026-05-05 | S-Sale | 38.568 | 2026-05-05 |
| Donovan Joanne M. | officer: CMO | 2026-05-04 | S-Sale | 31.2931 | 2026-05-05 |
| Fox Jonathan C | director | 2026-04-01 | A-Award | 0 | 2026-04-03 |
| Donovan Joanne M. | officer: CMO | 2026-04-01 | M-Exempt | 7.08 | 2026-04-02 |
| Donovan Joanne M. | officer: CMO | 2026-04-01 | M-Exempt | 7.08 | 2026-04-02 |
| Donovan Joanne M. | officer: CMO | 2026-04-01 | S-Sale | 32.3109 | 2026-04-02 |
| Donovan Joanne M. | officer: CMO | 2026-03-31 | M-Exempt | 7.08 | 2026-03-31 |
| Donovan Joanne M. | officer: CMO | 2026-03-31 | M-Exempt | 7.08 | 2026-03-31 |
| Donovan Joanne M. | officer: CMO | 2026-03-31 | S-Sale | 32.1168 | 2026-03-31 |
| Donovan Joanne M. | officer: CMO | 2026-03-27 | S-Sale | 30.9778 | 2026-03-30 |
| Donovan Joanne M. | officer: CMO | 2026-03-27 | S-Sale | 30.9778 | 2026-03-30 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 0.71 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 1.93 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | S-Sale | 29.44 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | S-Sale | 29.44 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | S-Sale | 29.44 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | S-Sale | 29.44 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 1.93 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 0.64 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 0.39 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | S-Sale | 29.44 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 0.71 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 0.39 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 1.93 | 2026-01-23 |
| Edris Badreddin | director | 2026-01-21 | M-Exempt | 0.64 | 2026-01-23 |
| Fox Jonathan C | director | 2026-01-02 | A-Award | 0 | 2026-01-05 |
| Martin Christopher Nathan | director | 2025-11-19 | A-Award | 22.34 | 2025-11-24 |
| Martin Christopher Nathan | 2025-11-19 | 0 | 2025-11-24 | ||
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-11-12 | M-Exempt | 0.18 | 2025-11-13 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-11-12 | M-Exempt | 0.18 | 2025-11-13 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-11-12 | S-Sale | 21.1245 | 2025-11-13 |
| Fox Jonathan C | director | 2025-11-11 | P-Purchase | 18.6358 | 2025-11-13 |
| Nofi Michael | officer: Chief Financial Officer | 2025-11-10 | A-Award | 18.28 | 2025-11-13 |
| Nofi Michael | officer: Chief Financial Officer | 2025-11-10 | A-Award | 0 | 2025-11-13 |
| Nofi Michael | 2025-11-10 | 0 | 2025-11-13 | ||
| Fox Jonathan C | director | 2025-10-01 | A-Award | 0 | 2025-10-02 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-26 | M-Exempt | 0.18 | 2025-08-28 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-26 | M-Exempt | 0.18 | 2025-08-28 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-26 | S-Sale | 14.5976 | 2025-08-28 |
| Blaustein Robert | officer: Chief Development Officer | 2025-08-12 | A-Award | 13.39 | 2025-08-14 |
| Blaustein Robert | officer: Chief Development Officer | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| MOORE JOHN R | officer: General Counsel | 2025-08-12 | A-Award | 13.39 | 2025-08-14 |
| MOORE JOHN R | officer: General Counsel | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| MOORE JOHN R | officer: General Counsel | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| MOORE JOHN R | officer: General Counsel | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| MOORE JOHN R | officer: General Counsel | 2025-08-12 | S-Sale | 13.3924 | 2025-08-14 |
| Derakhshan Behrad | officer: Chief Business Officer | 2025-08-12 | A-Award | 13.39 | 2025-08-14 |
| Derakhshan Behrad | officer: Chief Business Officer | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| Derakhshan Behrad | officer: Chief Business Officer | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| Derakhshan Behrad | officer: Chief Business Officer | 2025-08-12 | S-Sale | 13.3924 | 2025-08-14 |
| Derakhshan Behrad | officer: Chief Business Officer | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| Carruthers R Michael | officer: Chief Financial Officer | 2025-08-12 | A-Award | 13.39 | 2025-08-14 |
| Carruthers R Michael | officer: Chief Financial Officer | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| Carruthers R Michael | officer: Chief Financial Officer | 2025-08-12 | S-Sale | 13.3924 | 2025-08-14 |
| Carruthers R Michael | officer: Chief Financial Officer | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| Carruthers R Michael | officer: Chief Financial Officer | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-12 | A-Award | 13.39 | 2025-08-14 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-12 | S-Sale | 13.3924 | 2025-08-14 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| KOCH KEVIN | director, officer: President and CEO | 2025-08-12 | A-Award | 13.39 | 2025-08-14 |
| KOCH KEVIN | director, officer: President and CEO | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| KOCH KEVIN | director, officer: President and CEO | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| KOCH KEVIN | director, officer: President and CEO | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| KOCH KEVIN | director, officer: President and CEO | 2025-08-12 | S-Sale | 13.3924 | 2025-08-14 |
| Donovan Joanne M. | officer: CMO | 2025-08-12 | A-Award | 13.39 | 2025-08-14 |
| Donovan Joanne M. | officer: CMO | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| Donovan Joanne M. | officer: CMO | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| Donovan Joanne M. | officer: CMO | 2025-08-12 | S-Sale | 13.3924 | 2025-08-14 |
| Donovan Joanne M. | officer: CMO | 2025-08-12 | M-Exempt | 0 | 2025-08-14 |
| Fox Jonathan C | director | 2025-07-01 | A-Award | 0 | 2025-07-02 |
| Brege Laura | director | 2025-06-16 | A-Award | 14.68 | 2025-06-18 |
| Edris Badreddin | director | 2025-06-16 | A-Award | 14.68 | 2025-06-18 |
| Fox Jonathan C | director | 2025-06-16 | A-Award | 14.68 | 2025-06-18 |
| Morris Arlene | director | 2025-06-16 | A-Award | 14.68 | 2025-06-18 |
| ROOT JONATHAN D | director | 2025-06-16 | A-Award | 14.68 | 2025-06-18 |
| Thompson Peter A. | director, 10 percent owner: | 2025-06-16 | A-Award | 14.68 | 2025-06-18 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-05-01 | M-Exempt | 0 | 2025-05-07 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-05-02 | S-Sale | 16.4542 | 2025-05-07 |
| Russell Alan J | director, officer: Chief Scientific Officer | 2025-05-01 | M-Exempt | 0 | 2025-05-07 |
| MOORE JOHN R | officer: General Counsel | 2025-05-01 | M-Exempt | 0 | 2025-05-07 |
| MOORE JOHN R | officer: General Counsel | 2025-05-02 | S-Sale | 16.4542 | 2025-05-07 |
| MOORE JOHN R | officer: General Counsel | 2025-05-01 | M-Exempt | 0 | 2025-05-07 |